<DOC>
	<DOCNO>NCT00968422</DOCNO>
	<brief_summary>The objective study assess safety , tolerability , pharmacokinetics pharmacodynamics ABT-384 elderly subject .</brief_summary>
	<brief_title>A Study Safety , Tolerability , Pharmacokinetics , Pharmacodynamics ABT-384 Elderly Subjects</brief_title>
	<detailed_description />
	<criteria>1 . Age 65 year great 2 . Judged condition general good health base result medical history , physical examination , vital sign , laboratory profile 12lead ECG 1 . Use protocolprohibited medication within 2 week prior study drug administration . 2 . Positive urine drug screen nonprescribed drug abuse include alcohol . 3 . Receipt drug depot injection within 30 day prior study drug administration . 4 . Receipt investigational product within 6 week prior study drug administration . 5 . History significant sensitivity allergy drug . 6 . History drug alcohol abuse within 2 year . 7 . Positive test result HBV , HCV HIV . 8 . Estimated creatinine clearance &lt; 30 mL/min . 9 . Donation loss 5 mL/kg blood volume receipt blood product within 8 week prior study drug administration . 10 . Current enrollment another clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Pharmacology</keyword>
	<keyword>Drug Safety</keyword>
	<keyword>Phase 1 Clinical Trials</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>